Company intelligence / Profile preview

Efoora

Northbrook, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Efoora was a biotechnology company focused on the development and manufacturing of rapid diagnostic tests and point-of-care medical devices. The company specialized in immunoassays for infectious diseases, most notably a rapid HIV test, and developed technologies for glucose monitoring in diabetic patients. Headquartered in Illinois, Efoora sought to simplify complex laboratory procedures into user-friendly formats for clinical and home use. The company's operations were significantly impacted by legal and regulatory actions in the mid-2000s, eventually leading to its dissolution.

Therapeutic areas: OncologyEndocrinologyInfectious Diseases
Modalities: Diagnostic testDevice
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Efoora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Efoora.

Explore the full profile